Condition
Hepatoid Adenocarcinoma of Stomach clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hepatoid Adenocarcinoma of Stomach clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Perioperative albumin-bound paclitaxel plus SOX chemotherapy with sintilimab for HER2-negative hepatoid stomach cancer
This trial will try giving pre- and post-surgery chemo (albumin-bound paclitaxel and SOX) together with the immunotherapy drug sintilimab to people with locally advanced HER2-negative hepatoid stomach cancer to see if it shrinks tumors and improves outcomes.
-
Perioperative RC48 (Disitamab Vedotin) with sindillizumab and SOX for HER2‑expressing hepatoid stomach cancer
This trial tests whether giving Disitamab Vedotin (RC48) together with sindillizumab and SOX chemotherapy before and after surgery helps people with locally advanced HER2‑expressing hepatoid stomach cancer and is safe.
Quick answers
How many Hepatoid Adenocarcinoma of Stomach clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.